| DIRECT COMPETITOR COMPARISON | |
| PRXL | CVD | PPDI | Pvt1 | Industry | | Market Cap: | 722.24M | 3.41B | 2.53B | N/A | 77.69M | | Employees: | 9,275 | 8,826 | 10,000 | 21,0001 | 196 | | Qtrly Rev Growth (yoy): | -3.80% | 5.60% | -13.50% | N/A | 11.90% | | Revenue (ttm): | 1.23B | 1.92B | 1.44B | 2.70B1 | 56.04M | | Gross Margin (ttm): | 30.52% | 30.66% | 48.92% | N/A | 35.56% | | EBITDA (ttm): | 127.16M | 324.37M | 307.64M | N/A | -2.13M | | Oper Margins (ttm): | 5.84% | 12.45% | 16.95% | N/A | -5.87% | | Net Income (ttm): | 38.13M | 180.02M | 169.52M | N/A | N/A | | EPS (ttm): | 0.659 | 2.808 | 1.580 | N/A | N/A | | P/E (ttm): | 18.85 | 18.98 | 13.55 | N/A | 18.85 | | PEG (5 yr expected): | 0.99 | 1.49 | 2.11 | N/A | 1.43 | | P/S (ttm): | 0.60 | 1.80 | 1.78 | N/A | 1.80 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | CVD | | We Expect Ailing CROs to Recover
Wed, Nov 25 -
Morningstar.com | | • | CVD | | China Biotech Week in Review: CROs Consolidating
Sun, Nov 22 -
at Seeking Alpha | | • | CVD | | The Stockpickers: Fund managers hunt small-caps that can grow bigger
Fri, Nov 20 -
at MarketWatch | | • | CVD | | Zacks #5 Rank Additions for Friday
Fri, Nov 20 -
Zacks.com | | • | PPDI | | PPD Continues Rapid China Growth with Another CRO Acquisition
Thu, Nov 19 -
at Seeking Alpha | | • | PPDI | | PPD buying BioDuro in China expansion
Wed, Nov 18 -
AP | | • | PPDI | | PPD to Acquire BioDuro
Wed, Nov 18 -
Business Wire | | • | CVD | | Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
Wed, Nov 18 -
PR Newswire | | • | CVD | | Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
Wed, Nov 18 -
PR Newswire | | • | PPDI | | PPD and Janssen Pharmaceutica Collaborate to Develop Compounds for Treatment of Irritable Bowel Syndrome and Bacterial Infections
Mon, Nov 16 -
Business Wire | | • | CVD | | How Do You Say 'Drug Development' in Mandarin?
Thu, Nov 12 -
at Motley Fool | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 
Competitors
